NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $42.45 -1.51 (-3.43%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Establishment Labs alerts: Email Address About Establishment Labs Stock (NASDAQ:ESTA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Establishment Labs alerts:Sign Up Key Stats Today's Range$42.30▼$44.3250-Day Range$34.40▼$48.9952-Week Range$16.96▼$60.12Volume147,590 shsAverage Volume348,671 shsMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/APrice Target$56.60Consensus RatingModerate Buy Company OverviewEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Read More… Forget Trump and Kamala (Ad)I hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.THIS CALENDAR is the only thing that matters for you and your financial health right now. Establishment Labs Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 58th PercentileEstablishment Labs scored higher than 58% of companies evaluated by MarketBeat, and ranked 512th out of 1,006 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEstablishment Labs has only been the subject of 3 research reports in the past 90 days.Read more about Establishment Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($2.20) to ($1.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -13.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -13.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 59.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted20.18% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 15, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently decreased by 3.16%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted20.18% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 15, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently decreased by 3.16%, indicating that investor sentiment is improving. News and Social Media3.1 / 5News Sentiment0.64 News SentimentEstablishment Labs has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Establishment Labs this week, compared to 4 articles on an average week.Search Interest1 people have searched for ESTA on MarketBeat in the last 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $647,806.00 in company stock.Percentage Held by Insiders11.44% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address ESTA Stock News HeadlinesThermo Fisher Scientific Announces Expansion of Bioanalytical Laboratory Services in EuropeSeptember 18 at 8:58 AM | finance.yahoo.comAssam to strengthen cybersecurity with India's second national cyber forensics labSeptember 18 at 8:58 AM | msn.comAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt industries worth over $46 trillion. What's even more intriguing?September 20, 2024 | InvestorPlace (Ad)Food hygiene ratings given to 10 Kirklees establishmentsSeptember 17 at 5:54 PM | msn.comHappiness swings votes, and America's current mood could scramble expectations of young and old votersSeptember 17 at 5:54 PM | msn.comEstablishment Labs Holdings (ESTA) Rebounded in Q2August 26, 2024 | msn.comEstablishment Labs Holdings: A Cautious Hold Amid FDA Approval Process and High Short InterestAugust 23, 2024 | markets.businessinsider.comDeep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (5 Ratings)August 22, 2024 | benzinga.comSee More Headlines ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $25.89 at the beginning of the year. Since then, ESTA stock has increased by 64.0% and is now trading at $42.45. View the best growth stocks for 2024 here. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) released its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.51) by $0.11. Establishment Labs's revenue was down 9.2% on a year-over-year basis. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Top institutional shareholders of Establishment Labs include Nantahala Capital Management LLC (9.13%), Rice Hall James & Associates LLC (2.60%), William Blair Investment Management LLC (1.75%) and Sofinnova Investments Inc. (1.56%). Insiders that own company stock include Jw Asset Management, Llc, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy, Leslie Gillin and Edward J Schutter. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and Company Calendar Last Earnings8/06/2024Today9/20/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:ESTA CUSIPN/A CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees960Year FoundedN/APrice Target and Rating Average Stock Price Target$56.60 High Stock Price Target$70.00 Low Stock Price Target$45.00 Potential Upside/Downside+28.8%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-54.97% Pretax Margin-55.61% Return on Equity-220.67% Return on Assets-29.55% Debt Debt-to-Equity Ratio4.30 Current Ratio4.44 Quick Ratio2.91 Sales & Book Value Annual Sales$151.35 million Price / Sales7.99 Cash FlowN/A Price / Cash FlowN/A Book Value$0.71 per share Price / Book61.92Miscellaneous Outstanding Shares27,515,000Free Float24,367,000Market Cap$1.21 billion OptionableOptionable Beta1.20 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (NASDAQ:ESTA) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.